111 related articles for article (PubMed ID: 9816121)
21. The effect of the GM-CSF/IL-3 fusion protein PIXY321 on bone marrow and circulating haemopoietic cells of previously untreated patients with cancer.
Gheilmini M; Pettengell R; Coutinho LH; Testa N; Crowther D
Br J Haematol; 1996 Apr; 93(1):6-12. PubMed ID: 8611477
[TBL] [Abstract][Full Text] [Related]
22. Effect of cytokines on the proliferation/differentiation of stroma-initiating cells.
Yamada M; Suzu S; Tanaka-Douzono M; Wakimoto N; Hatake K; Hayasawa H; Motoyoshi K
J Cell Physiol; 2000 Sep; 184(3):351-5. PubMed ID: 10911366
[TBL] [Abstract][Full Text] [Related]
23. Effects of the hematopoietic growth factors GM-CSF, IL-3, and IL-6 on human tumor colony-forming units taken directly from patients.
Izquierdo MA; Degen D; Myers L; Levitt DJ; Von Hoff DD
Ann Oncol; 1995 Nov; 6(9):927-32. PubMed ID: 8624297
[TBL] [Abstract][Full Text] [Related]
24. Addition of granulocyte-colony stimulating factor (G-CSF) to adjuvant treatment may increase survival in patients with operable breast cancer: interaction of G-CSF with dormant micrometastatic breast cancer cells.
Altundag K; Altundag O; Elkiran ET; Cengiz M; Ozisik Y
Med Hypotheses; 2004; 63(1):56-8. PubMed ID: 15193347
[TBL] [Abstract][Full Text] [Related]
25. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.
Hohaus S; Martin H; Wassmann B; Egerer G; Haus U; Färber L; Burger KJ; Goldschmidt H; Hoelzer D; Haas R
Bone Marrow Transplant; 1998 Oct; 22(7):625-30. PubMed ID: 9818688
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-3 in hematology and oncology: current state of knowledge and future directions.
Mangi MH; Newland AC
Cytokines Cell Mol Ther; 1999 Jun; 5(2):87-95. PubMed ID: 10515681
[TBL] [Abstract][Full Text] [Related]
27. Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation.
Avigan D; Wu Z; Gong J; Joyce R; Levine J; Elias A; Richardson P; Milano J; Kennedy L; Anderson K; Kufe D
Clin Cancer Res; 1999 Oct; 5(10):2735-41. PubMed ID: 10537336
[TBL] [Abstract][Full Text] [Related]
28. Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells.
Obermueller E; Vosseler S; Fusenig NE; Mueller MM
Cancer Res; 2004 Nov; 64(21):7801-12. PubMed ID: 15520186
[TBL] [Abstract][Full Text] [Related]
29. Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces the osteoblastic differentiation of the human osteosarcoma cell line SaOS-2.
Postiglione L; Domenico GD; Montagnani S; Spigna GD; Salzano S; Castaldo C; Ramaglia L; Sbordone L; Rossi G
Calcif Tissue Int; 2003 Jan; 72(1):85-97. PubMed ID: 12232677
[TBL] [Abstract][Full Text] [Related]
30. Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB study.
Schiller JH; Hank JA; Khorsand M; Storer B; Borchert A; Huseby-Moore K; Burns D; Wesly O; Albertini MR; Wilding G; Sondel PM
Clin Cancer Res; 1996 Feb; 2(2):319-30. PubMed ID: 9816175
[TBL] [Abstract][Full Text] [Related]
31. Optimization of culture conditions to enhance transfection of human CD34+ cells by electroporation.
Wu MH; Smith SL; Danet GH; Lin AM; Williams SF; Liebowitz DN; Dolan ME
Bone Marrow Transplant; 2001 Jun; 27(11):1201-9. PubMed ID: 11551032
[TBL] [Abstract][Full Text] [Related]
32. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
[TBL] [Abstract][Full Text] [Related]
33. A GM-CSF/IL-3 fusion protein promotes neutrophil and platelet recovery in sublethally irradiated rhesus monkeys.
Williams DE; Dunn JT; Park LS; Frieden EA; Seiler FR; Farese AM; Macvittie TJ
Biotechnol Ther; 1993; 4(1-2):17-29. PubMed ID: 8374510
[TBL] [Abstract][Full Text] [Related]
34. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
Kinoshita Y; Kono T; Yasumoto R; Kishimoto T; Wang CY; Haas GP; Nishisaka N
J Immunother; 2001; 24(3):205-11. PubMed ID: 11394497
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of transcriptional activation of the immediate early gene Egr-1 in response to PIXY321.
Mignacca RC; Lee HJ; Kwon EM; Sakamoto KM
Blood; 1996 Aug; 88(3):848-54. PubMed ID: 8704240
[TBL] [Abstract][Full Text] [Related]
36. [Radioprotection of recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor on peripheral lymphocytes of rhesus monkey irradiated by 3.0 Gy gamma-rays].
Cui YF; Yang H; Luo QL; Dong B; Liu XL; Xu H; Mao BZ; Wang DW
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Jan; 16(1):22-5. PubMed ID: 14706198
[TBL] [Abstract][Full Text] [Related]
37. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
Stagg J; Wu JH; Bouganim N; Galipeau J
Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233
[TBL] [Abstract][Full Text] [Related]
38. Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells.
Pei XH; Nakanishi Y; Takayama K; Bai F; Hara N
Br J Cancer; 1999 Jan; 79(1):40-6. PubMed ID: 10408691
[TBL] [Abstract][Full Text] [Related]
39. [Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].
Meng FY; Xu B; Sun J; Yang Y; Niu JN
Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):1051-2. PubMed ID: 15447861
[TBL] [Abstract][Full Text] [Related]
40. Studies on the interaction between interleukin 6 and human malignant nonhematopoietic cell lines.
Serve H; Steinhauser G; Oberberg D; Flegel WA; Northoff H; Berdel WE
Cancer Res; 1991 Aug; 51(15):3862-6. PubMed ID: 1855204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
